Longitudinal midbrain changes in early Parkinson's disease: Iron content estimated from R2*/MRI

Parkinsonism and Related Disorders

Volumn 21, Issue 3, 2015, Pages 179-183

  Wieler, Marguerite ^a   Gee, Myrlene ^b   Martin, W R Wayne ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Iron; MRI; Parkinson's disease; Parkinsonism

Indexed keywords

IRON;

ADULT; AGED; ARTICLE; BASAL GANGLION; BRAIN LEVEL; BRAIN MAPPING; BRAIN SIZE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; FEMALE; HUMAN; LONGITUDINAL STUDY; MALE; MESENCEPHALON; MOTOR DYSFUNCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PARKINSON DISEASE; PARKINSON DISEASE QUESTIONNAIRE; PRIORITY JOURNAL; QUESTIONNAIRE; RELAXATION TIME; SUBSTANTIA NIGRA PARS COMPACTA; UNIFIED PARKINSON DISEASE RATING SCALE; ANALYSIS OF VARIANCE; CASE CONTROL STUDY; IMAGE PROCESSING; METABOLISM; MIDDLE AGED; PATHOLOGY; SEVERITY OF ILLNESS INDEX;

AGED; ANALYSIS OF VARIANCE; BASAL GANGLIA; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IRON; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MESENCEPHALON; MIDDLE AGED; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX;

EID: 84923261559     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2014.11.017     Document Type: Article

References (26)

1. Greffard S., Verny M., Bonnet A.M., Beinis J.Y., Gallinari C., Meaume S., et al. Motor score of the Unified Parkinson Disease Rating Scale as a good predictor of Lewy body-associated neuronal loss in the substantia nigra. Arch Neurol 2006, 63:584-588.
2. Lee C.S., Schulzer M., Mak E.K., Snow B.J., Tsui J.K., Calne S., et al. Clinical observations on the rate of progression of idiopathic parkinsonism. Brain 1994, 117:501-507.
3. Sofic E., Riederer P., Heinsen H., Beckmann H., Reynolds G.P., Hebenstreit G., et al. Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain. JNeural Transm Gen Sect 1988, 74:199-205.
4. Dexter D.T., Wells F.R., Lees A.J., Agid F., Agid Y., Jenner P., et al. Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. JNeurochem 1989, 52:1830-1836.
5. Youdim M.B., Ben-Shachar D., Yehuda S., Riederer P. The role of iron in the basal ganglion. Adv Neurol 1990, 53:155-162.
6. Ye F.Q., Allen P.S., Martin W.R. Basal ganglia iron content in Parkinson's disease measured with magnetic resonance. Mov Disord 1996, 11:243-249.
7. Martin W.R., Wieler M., Gee M. Midbrain iron content in early Parkinson disease: a potential biomarker of disease status. Neurology 2008, 70:1411-1417.
8. Wild J.M., Martin W.R., Allen P.S. Multiple gradient echo sequence optimized for rapid, single-scan mapping of R(2)(*) at high B0. Magn Reson Med 2002, 48:867-876.
9. Ye F.Q., Martin W.R., Allen P.S. Estimation of brain iron invivo by means of the interecho time dependence of image contrast. Magn Reson Med 1996, 36:153-158.
10. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. JNeurol Neurosurg Psychiatr 1992, 55:181-184.
11. Martin W.R., Wieler M., Stoessl A.J., Schulzer M. Dihydrotetrabenazine positron emission tomography imaging in early, untreated Parkinson's disease. Ann Neurol 2008, 63:388-394.
12. Fahn S., Elton R.L., UPDRS Development Committee Unified Parkinson's Disease Rating Scale. Recent developments in Parkinson's disease 1987, 153-163. Macmillan, Florham Park, NJ. S. Fahn, C.D. Marsden, D. Calne, M. Goldstein (Eds.).
13. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. JPsychiatr Res 1975, 12:189-198.
14. Podsiadlo D., Richardson S. The timed "up & go": a test of basic functional mobility for frail elderly persons. JAm Geriatr Soc 1991, 39:142-148.
15. Peto V., Jenkinson C., Fitzpatrick R. PDQ-39: a review of the development, validation and application of a Parkinson's disease quality of life questionnaire and its associated measures. JNeurol 1998, 245:S10-S14.
16. Talairach J.T.P. Co-planar stereotaxic atlas of the human brain: 3-dimensional proportional system: an approach to cerebral imaging 1988, Thieme Medical Publishers, New York.
17. Fearnley J.M., Lees A.J. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991, 114:2283-2301.
18. Hallgren B., Sourander P. The effect of age on the non-haemin iron in the human brain. JNeurochem 1958, 3:41-51.
19. Grabill C., Silva A.C., Smith S.S., Koretsky A.P., Rouault T.A. MRI detection of ferritin iron overload and associated neuronal pathology in iron regulatory protein-2 knockout mice. Brain Res 2003, 971:95-106.
20. Oikawa H., Sasaki M., Tamakawa Y., Ehara S., Tohyama K. The substantia nigra in Parkinson disease: proton density-weighted spin-echo and fast short inversion time inversion-recovery MR findings. AJNR Am J Neuroradiol 2002, 23:1747-1756.
21. Duguid J.R., De La Paz R., DeGroot J. Magnetic resonance imaging of the midbrain in Parkinson's disease. Ann Neurol 1986, 20:744-747.
22. Stern M.B., Braffman B.H., Skolnick B.E., Hurtig H.I., Grossman R.I. Magnetic resonance imaging in Parkinson's disease and parkinsonian syndromes. Neurology 1989, 39:1524-1526.
23. Jin L., Wang J., Zhao L., Jin H., Fei G., Zhang Y., et al. Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease. Brain 2011, 134:50-58.
24. Bunzeck N., Singh-Curry V., Eckart C., Weiskopf N., Perry R.J., Bain P.G., et al. Motor phenotype and magnetic resonance measures of basal ganglia iron levels in Parkinson's disease. Parkinsonism Relat Disord 2013, 19:1136-1142.
25. 2* a new MRI biomarker for the progression of Parkinson's disease? A longitudinal follow-up. PLoS One 2013, 8:e57904.
26. Rossi M.E., Ruottinen H., Saunamaki T., Elovaara I., Dastidar P. Imaging brain iron and diffusion patterns: a follow-up study of Parkinson's disease in the initial stages. Acad Radiol 2014, 21:64-71.